These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 2555424)

  • 1. [Effect of estrogen replacement therapy on the serum osteocalcin level in the postmenopausal and castrated women].
    Honjo S; Mizunuma H; Soda M; Igarashi M
    Nihon Sanka Fujinka Gakkai Zasshi; 1989 Oct; 41(10):1571-6. PubMed ID: 2555424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of vitamin K2 treatment on carboxylation of osteocalcin in early postmenopausal women.
    Yasui T; Miyatani Y; Tomita J; Yamada M; Uemura H; Miura M; Irahara M
    Gynecol Endocrinol; 2006 Aug; 22(8):455-9. PubMed ID: 17012108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Different effects of oral conjugated equine estrogens and transdermal estrogen on undercarboxylated osteocalcin concentration in postmenopausal women.
    Yasui T; Uemura H; Tomita J; Umino Y; Yamada M; Kuwahara A; Matsuzaki T; Maegawa M; Miura M; Irahara M
    Menopause; 2006; 13(4):651-9. PubMed ID: 16837887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nitroglycerin therapy is as efficacious as standard estrogen replacement therapy (Premarin) in prevention of oophorectomy-induced bone loss: a human pilot clinical study.
    Wimalawansa SJ
    J Bone Miner Res; 2000 Nov; 15(11):2240-4. PubMed ID: 11092405
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral 1,25-dihydroxyvitamin D administration in osteoporotic women: effects of estrogen therapy.
    Cosman F; Nieves J; Shen V; Lindsay R
    J Bone Miner Res; 1995 Apr; 10(4):594-600. PubMed ID: 7610930
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is skeletal responsiveness to thyroid hormone altered in primary osteoporosis or following estrogen replacement therapy?
    Langdahl BL; Loft AG; Møller N; Weeke J; Eriksen EF; Mosekilde L; Charles P
    J Bone Miner Res; 1997 Jan; 12(1):78-88. PubMed ID: 9240729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis.
    Garnero P; Sornay-Rendu E; Chapuy MC; Delmas PD
    J Bone Miner Res; 1996 Mar; 11(3):337-49. PubMed ID: 8852944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical application of undercarboxylated osteocalcin].
    Yasui T; Yamada M; Irahara M
    Clin Calcium; 2007 Nov; 17(11):1709-16. PubMed ID: 17982191
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Serum osteocalcin in children with chronic renal insufficiency].
    Peco-Antić A; Nastić-Mirić D; Milikić V; Babić D; Pejcić I; Kostić M; Paripović V; Jovanović O; Kruscić D; Mancić J
    Srp Arh Celok Lek; 1996; 124(9-10):227-31. PubMed ID: 9102853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Change in serum undercarboxylated osteocalcin concentration in bilaterally oophorectomized women.
    Yasui T; Uemura H; Tomita J; Miyatani Y; Yamada M; Kuwahara A; Matsuzaki T; Maegawa M; Miura M; Irahara M
    Maturitas; 2007 Mar; 56(3):288-96. PubMed ID: 17030103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes of bone formation markers osteocalcin and bone-specific alkaline phosphatase in postmenopausal women with osteoporosis.
    Lumachi F; Ermani M; Camozzi V; Tombolan V; Luisetto G
    Ann N Y Acad Sci; 2009 Sep; 1173 Suppl 1():E60-3. PubMed ID: 19751416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The long-term effect of menopause on postmenopausal bone loss in Japanese women: results from a prospective study.
    Okano H; Mizunuma H; Soda M; Kagami I; Miyamoto S; Ohsawa M; Ibuki Y; Shiraki M; Suzuki T; Shibata H
    J Bone Miner Res; 1998 Feb; 13(2):303-9. PubMed ID: 9495525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of modal damping factor as a diagnostic tool for osteoporosis and its relation with serum osteocalcin and collagen I N-telopeptide for monitoring the efficacy of alendronate in ovariectomized rats.
    Christopoulou GE; Stavropoulou A; Anastassopoulos G; Panteliou SD; Papadaki E; Karamanos NK; Panagiotopoulos E
    J Pharm Biomed Anal; 2006 Jun; 41(3):891-7. PubMed ID: 16488571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The usefulness of biochemical bone markers in predicting the response of hormone replacement therapy in perimenopausal cigarette smoking healthy women.
    Cubrilo-Turek M; Stavljenić-Rukavina A; Turek S; Kusec V; Duraković Z
    Coll Antropol; 1999 Jun; 23(1):195-201. PubMed ID: 10402723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Common biochemical markers of bone turnover predict future bone loss: a 5-year follow-up study.
    Löfman O; Magnusson P; Toss G; Larsson L
    Clin Chim Acta; 2005 Jun; 356(1-2):67-75. PubMed ID: 15936304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Lumbar bone density and serum osteocalcin in pre- and postmenopausal women].
    Masahashi T; Asai M; Okamoto T; Suzuki M; Noguchi M; Nakanishi M; Tomita A
    Nihon Sanka Fujinka Gakkai Zasshi; 1990 Jul; 42(7):727-31. PubMed ID: 2212811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of hormone-replacement therapy on fibrinolysis in postmenopausal women.
    Koh KK; Mincemoyer R; Bui MN; Csako G; Pucino F; Guetta V; Waclawiw M; Cannon RO
    N Engl J Med; 1997 Mar; 336(10):683-90. PubMed ID: 9041098
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Undercarboxylated osteocalcin concentration in postmenopausal women receiving hormone therapy daily and on alternate days.
    Yasui T; Uemura H; Umino Y; Yamada M; Kuwahara A; Matsuzaki T; Maegawa M; Furumoto H; Miura M; Irahara M
    Menopause; 2006; 13(2):314-22. PubMed ID: 16645545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The changes in circulating osteoprotegerin after hormone therapy in postmenopausal women and their relationship with oestrogen responsiveness on bone.
    Han KO; Choi JT; Choi HA; Moon IG; Yim CH; Park WK; Yoon HK; Han IK
    Clin Endocrinol (Oxf); 2005 Mar; 62(3):349-53. PubMed ID: 15730418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vitamin K(2) (menaquinone 4) reduces serum undercarboxylated osteocalcin level as early as 2 weeks in elderly women with established osteoporosis.
    Miki T; Nakatsuka K; Naka H; Kitatani K; Saito S; Masaki H; Tomiyoshi Y; Morii H; Nishizawa Y
    J Bone Miner Metab; 2003; 21(3):161-5. PubMed ID: 12720050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.